ASSOCIATION OF LEPTIN WITH TYPE 2 DIABETES IN NON-OBESE SUBJECTS
Abstract
Background: South Asians have a high tendency to develop type 2 diabetes even at low BMI. Weevaluated serum leptin levels in a group of non-obese type 2 diabetics. Methods: An observational studyconducted on 90 subjects, 55 with Type 2 diabetes mellitus, and 35 normal controls (non-diabetics).BMI, waist circumference, serum leptin, and serum glucose were measured. The correlation betweenthese variables was studied by multiple regression analysis. Results: Serum leptin levels were positivelycorrelated with BMI in obese (r=0.976) and non-obese diabetics (r=0.956). Serum leptin was relatedwith diabetes (r= -0.153, p=0.001). Serum leptin was highly correlated with waist circumference inobese than non-obese diabetics, (r=0.753). Mean serum leptin level was 21.4 ηg/ml in non-obesediabetics and 34.9 ηg/ml in diabetic group. It is even lower than the non-obese, non-diabetics (23.3ηg/ml). Multivariate linear regression analysis between leptin and age, weight, BMI, waist circumferencein patients shows only a strong association with BMI in diabetics (p=0.0001), while in non-diabetic itwas not significant (p=0.07). Serum leptin was high in diabetics taking oral hypoglycaemic (37.8±19.1ηg/ml), while it was low in diabetics taking insulin injections (29.3±24.2 ηg/ml). Conclusion: Lowleptin levels are associated with type 2 diabetes mellitus independent of changes in BMI.Keywords: Leptin, BMI, waist circumference, type-2 diabetes mellitus, serum glucose.References
Diabetes in people of South Asian origin in the UK. Available at:
http://diabetesuffolk.com/UnderstandingDiabetes/Diabetesin
SouthAsians.htm
Boden G. Pathogenesis of type 2 diabetes, insulin resistance.
Endocrinol Metabo Clin North Am 2001;30:801–15.
Boden G. Role of fatty acids in the pathogenesis of insulin
resistance and NIDDM. Diabetes 1997;46:3–10.
Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM.
The role of lipids in the pathogenesis of muscle insulin
resistance and β-cell failure in type II diabetes and obesity. Exp
Clin Endocrinol Diabetes 2001;109(Suppl-2):S189–S201.
Considine RV, Sinha MK, Heinman ML, Kriauciunas
A, Stephens TW, Nyce MR, et al. Serum immunoreactive
leptin concentrations in normal-weight and obese humans. N
Engl J Med 1996;334:292–5.
Sivitz WL, Walsh SA, Morgan DA, Thomas MJ, Haynes
WG. Effects of leptin on insulin sensitivity in normal rats.
Endocrinol 1997;138:3395–401.
Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Wnters
D, Boone T, et al. Effects of the obese gene product on body
weight regulation in ob/ob mice. Science 1995;268:540–3.
Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron
MJ. Acute stimulation of glucose metabolism in mice by
leptin treatment. Nature 1997;389:374–7.
Kieffer TJ, Habener JF. The adipoinsular axis: effects of
leptin on pancreatic β-cells. Am J Physiol Endocrinol
Metab 2000;278(1):E1–E14.
Al-Shoumer KA, Vasanthy BK, Makhlouf HA, Al-Zaid MM.
Leptin levels in Arabs with primary hyperthyroidism. Ann
Saudi Med 2000;20(2):113–8.
Clement K, Lahlou N, Ruiz J, Hager J, Bougnères
P, Basdevant A, et al. Association of poorly controlled
diabetes with low serum leptin level in morbid obesity. Int J
Obes1997;21:556–61.
Roden M, Ludwig C, Nowotny P, Schneider B, Clodi
M, Vierhapper H, et al. Relative hypoleptinemia in patients
with type 1 and type 2 diabetes mellitus. Int J Obesity Relat
Metab Disoord 2000; 24:976–81.
J Ayub Med Coll Abbottabad 2012;24(3-4)
http://www.ayubmed.edu.pk/JAMC/24-3/Kazmi.pdf 189
Widjaja A, Stratton IM, Horn R, Holman RR, Turner R,
Brabant G. UKPD 20: Plasma leptin, obesity, and plasma
insulin in type 2 diabetes subjects. J Clin Endocrinol Metab
;82:654–7.
Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL.
Leptin concentrations in diabetic and non-diabetic MexicanAmericans. Diabetes 1996;45:822–4.
Guler S, Cakir B, Demirbas B, Gursony G, Serter R, Araf Y.
Leptin concentrations are related to glycemic control, but do
not change with short-term oral antidiabetic therapy in female
patients with type 2 diabetes. Diabetes Obes Metab
;2:313–6.
Schwartz MW, Prigeon RL, Kahn SE, Nicolson M, Moore
J, Morawiecki A, et al. Evidence that plasma leptin and
insulin levels are associated body adiposity via different
mechanisms. Diabetes Care 1997;20:1476–81.
Soliman AT, Omar M, Assem HM, Nasr IS, Rizk MM, El
Matary W, et al. Serum leptin concentrations in children with
type 1 diabetes mellitus: relationship to body mass index,
insulin dose, and glycemic control. Metabolism 2002;51:292–6.
Sivitz WI, Walsh S, Morgan D, Donohoue P, Haynes W,
Leibel RL. Plasma leptin in diabetic and insulin-treated
diabetic and normal rats. Metabolism. 1998;47:584–91.
Havel PJ, Uriu-Hare JY, Liu T, Stanhope KL, Stern JS, Keen
CL, et al. Marked and rapid decreases of circulating leptin in
streptozotocin diabetic rats: reversal by insulin. Am J Physiol
;274(5 pt 2):R1482–91.
Marita AR, Sarkar JA, Rane S. Type 2 diabetes in non-obese
Indian subjects is associated with reduced leptin levels: study
from Mumbai, Western India. Mol Cell Biochem.
;275(1–2):143–51.
Kirel B, Dogruel N, Korkmaz U, Kilic FS, Ozdamar K, Ucar
B. Serum leptin levels in type 1 diabetes and obese children:
relation to insulin levels. Clin Biochem 2000;33:475–80.
Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang
Y, et al, Leptin levels in human and rodent: Measurement of
plasma leptin and ob RNA in obese and weight-reduced
subjects. Nat Med 1995;1:1155–61.
Horwitz D, Kuzuya H, Rubenstein AH. Circulating serum Cpeptide. N Engl J Med 1979;295:207–9.
Ruhl CE, Everhart JE. Leptin concentrations in the United
States: relations with demographic and anthropometric
measures. Am J Clin Nutr 2001;74(3):295–301.
Kalhan R, Puthawala K, Agarwal S, Amini SB, Kalhan SC.
Altered lipid profile, leptin, insulin, and anthropometry in
offspring of South Asian immigrants in the United States.
Metabolism 2001;50:1197–202.
Published
Issue
Section
License
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
